Clinical Trials Directory

Trials / Unknown

UnknownNCT00734123

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

Early Detection of Atherosclerosis in the Primary Care Setting: a Randomized Trial to Assess the Efficacy of a Novel Strategy in the Primary Prevention of Cardiovascular Diseases.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
2,948 (estimated)
Sponsor
Hospital Arnau de Vilanova · Academic / Other
Sex
All
Age
40 Years – 74 Years
Healthy volunteers
Accepted

Summary

The incidence of cardiovascular diseases is still high and further efforts should be done in primary prevention. The main objective is to quantify the burden of subclinical atherosclerosis using non-invasive techniques,and to study the impact of this assessment and consequent treatment in the progression of atherosclerosis and in the incidence of cardiovascular diseases.

Detailed description

We will perform non-invasive techniques (carotid Intima-Media Thickness, CAC score and ankle-brachial index) to individuals at intermediate cardiovascular risk.With these results, we will classify participants in: no atherosclerosis, mild, moderate and severe atherosclerosis, and therapeutic targets will be set according to pre-defined algorithms. The end-point will be the course of atherosclerosis measured by cIMT/CAC score (2 years) and the incidence of CVD at 5 years of follow-up.

Conditions

Interventions

TypeNameDescription
DRUGSimvastatin or AtorvastatinSimvastatin 10-40 mg or Atorvastatin 20-40 mg will be prescribed according to LDL cholesterol reduction target.
DRUGEnalaprilEnalapril 10 mg/day will be prescribed as the initial treatment. Doses and adding drugs will be titrated accordingly
DRUGAspirin or clopidogrelAspirin 100 mg or clopidogrel 75 mg/ per day
DRUGRimonabantIn both arms, we will follow the standard clinical care in terms of treatments, as far as obesity and diabetes mellitus is concerned. Drugs will be prescribed as the standard clinical care

Timeline

Start date
2008-04-01
Primary completion
2009-04-01
Completion
2013-05-01
First posted
2008-08-14
Last updated
2008-08-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00734123. Inclusion in this directory is not an endorsement.